ferrous fumarate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4261	141-01-5

Description:

Molecule	Description
Synonyms: ferrous fumarate iron fumarate	used in treatment of iron deficiency anemia; RN given refers to Fe(+2)[1:1] salt Molecular weight: 169.90 Formula: C4H2FeO4 CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: ALOGS: ROTB: None

Molecule

Description

Synonyms:

ferrous fumarate
iron fumarate

used in treatment of iron deficiency anemia; RN given refers to Fe(+2)[1:1] salt

Molecular weight: 169.90
Formula: C4H2FeO4
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA:
ALOGS:
ROTB: None

Drug dosage:

Dose	Unit	Route
0.20	g	O

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
July 18, 1986	FDA	GD SEARLE LLC

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Red blood cell sedimentation rate abnormal	126.70	14.82	69	13300	16274	50575481
Disability	104.78	14.82	56	13313	12719	50579036
C-reactive protein abnormal	95.29	14.82	70	13299	27739	50564016
Acute kidney injury	82.25	14.82	184	13185	227874	50363881
Hyponatraemia	81.36	14.82	113	13256	96026	50495729
Haematocrit decreased	81.13	14.82	70	13299	34906	50556849
Red blood cell count decreased	75.01	14.82	66	13303	33769	50557986
Multiple fractures	74.72	14.82	36	13333	6575	50585180
Presbyacusis	67.53	14.82	26	13343	2750	50589005
C-reactive protein increased	66.77	14.82	85	13284	66389	50525366
Pleural thickening	58.47	14.82	23	13346	2576	50589179
Blood magnesium increased	56.18	14.82	23	13346	2857	50588898
Pleural fibrosis	52.61	14.82	23	13346	3361	50588394
Confusional state	49.87	14.82	134	13235	185794	50405961
Fall	46.41	14.82	193	13176	334739	50257016
Deafness neurosensory	46.34	14.82	23	13346	4478	50587277
Epigastric discomfort	46.08	14.82	25	13344	5845	50585910
Femur fracture	40.95	14.82	50	13319	37414	50554341
Heart rate	40.93	14.82	8	13361	59	50591696
Blood pressure measurement	40.31	14.82	10	13359	239	50591516
Drug-induced liver injury	38.26	14.82	42	13327	28053	50563702
Large intestine polyp	35.86	14.82	23	13346	7309	50584446
Hyperkalaemia	35.47	14.82	53	13316	48036	50543719
Starvation ketoacidosis	34.68	14.82	7	13362	62	50591693
Haemoglobin decreased	34.38	14.82	92	13277	127124	50464631
Musculoskeletal pain	33.86	14.82	65	13304	72112	50519643
Metabolic encephalopathy	32.57	14.82	19	13350	5102	50586653
Blood lactic acid	31.88	14.82	7	13362	96	50591659
Osteopenia	31.46	14.82	30	13339	16988	50574767
Blindness cortical	30.98	14.82	9	13360	397	50591358
Colitis microscopic	30.77	14.82	20	13349	6500	50585255
Blood pressure diastolic decreased	29.92	14.82	29	13340	16752	50575003
Upper gastrointestinal haemorrhage	29.14	14.82	28	13341	16007	50575748
Hip fracture	28.97	14.82	35	13334	25896	50565859
Orthostatic hypotension	28.48	14.82	37	13332	29444	50562311
Hippocampal sclerosis	27.55	14.82	6	13363	79	50591676
Cyst	27.45	14.82	24	13345	12163	50579592
Cerebellar haematoma	27.45	14.82	8	13361	357	50591398
Chorea	27.16	14.82	11	13358	1329	50590426
Abdominal discomfort	26.63	14.82	14	13355	231627	50360128
Thyroiditis acute	26.46	14.82	6	13363	96	50591659
Parkinsonian rest tremor	26.29	14.82	6	13363	99	50591656
Alopecia	25.09	14.82	17	13352	245030	50346725
Skin depigmentation	24.63	14.82	9	13360	823	50590932
Blood pressure systolic increased	24.62	14.82	38	13331	35411	50556344
Narrow anterior chamber angle	24.60	14.82	5	13364	46	50591709
Joint swelling	24.08	14.82	128	13241	245158	50346597
Swelling	23.29	14.82	12	13357	200860	50390895
Periodic limb movement disorder	22.66	14.82	6	13363	187	50591568
Hypomagnesaemia	22.27	14.82	29	13340	23127	50568628
Infected neoplasm	21.80	14.82	6	13363	217	50591538
Megacolon	21.45	14.82	10	13359	1696	50590059
Body temperature decreased	21.44	14.82	24	13345	16371	50575384
Blood potassium increased	21.44	14.82	24	13345	16374	50575381
Contraindicated product administered	20.67	14.82	86	13283	148872	50442883
Hypovolaemic shock	19.91	14.82	14	13355	5174	50586581
Ear infection viral	19.86	14.82	5	13364	127	50591628
Aura	19.72	14.82	8	13361	970	50590785
Renal impairment	19.70	14.82	54	13315	75607	50516148
Circulatory collapse	19.16	14.82	25	13344	19975	50571780
Hypocalcaemia	18.98	14.82	29	13340	26787	50564968
Temporal lobe epilepsy	18.80	14.82	6	13363	364	50591391
Dermatitis psoriasiform	18.40	14.82	9	13360	1697	50590058
Mixed anxiety and depressive disorder	18.38	14.82	5	13364	173	50591582
Wheezing	17.89	14.82	46	13323	62001	50529754
Osteoporosis	16.99	14.82	37	13332	44842	50546913
Reperfusion arrhythmia	16.92	14.82	5	13364	234	50591521
Haematemesis	16.89	14.82	28	13341	27697	50564058
Pain of skin	16.60	14.82	15	13354	7932	50583823
Eye pain	16.36	14.82	28	13341	28421	50563334
New onset diabetes after transplantation	16.23	14.82	4	13365	93	50591662
Otitis externa	16.14	14.82	8	13361	1552	50590203
Peripheral swelling	15.97	14.82	101	13268	205835	50385920
Sinusitis	15.94	14.82	13	13356	170545	50421210
Foetal exposure during pregnancy	15.83	14.82	27	13342	27332	50564423
Initial insomnia	15.56	14.82	12	13357	5103	50586652
Rheumatoid arthritis	15.50	14.82	99	13270	202451	50389304
Pain in extremity	15.45	14.82	124	13245	272741	50319014
Asthenia	15.31	14.82	39	13330	319003	50272752
Hepatobiliary infection	15.13	14.82	3	13366	24	50591731
Sleep disorder	15.02	14.82	41	13328	57242	50534513
Osteoarthritis	15.00	14.82	46	13323	68560	50523195
Intracranial haematoma	14.98	14.82	5	13364	350	50591405
Duodenal perforation	14.89	14.82	6	13363	715	50591040

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Clear cell renal cell carcinoma	115.90	19.67	28	4796	987	29568716
Lymphoproliferative disorder	94.85	19.67	29	4795	2498	29567205
Acute kidney injury	43.23	19.67	117	4707	265150	29304553
Congenital oesophageal anomaly	41.51	19.67	8	4816	93	29569610
Fall	40.39	19.67	89	4735	177089	29392614
Meconium abnormal	38.46	19.67	7	4817	58	29569645
Neutropenic sepsis	36.16	19.67	23	4801	11704	29557999
Confusional state	35.86	19.67	70	4754	127807	29441896
Polyhydramnios	34.47	19.67	8	4816	236	29569467
Upper gastrointestinal haemorrhage	33.27	19.67	28	4796	21886	29547817
High frequency ablation	31.51	19.67	7	4817	169	29569534
Microcytic anaemia	31.42	19.67	12	4812	2019	29567684
Renal cell carcinoma	30.41	19.67	15	4809	4681	29565022
Paraneoplastic rash	30.30	19.67	6	4818	81	29569622
Necrotising enterocolitis neonatal	30.25	19.67	7	4817	204	29569499
Hyponatraemia	29.42	19.67	45	4779	67588	29502115
Haematemesis	28.52	19.67	27	4797	24599	29545104
Epileptic encephalopathy	28.33	19.67	6	4818	115	29569588
Femoral neck fracture	27.68	19.67	12	4812	2791	29566912
Apnoeic attack	27.52	19.67	7	4817	305	29569398
Skin plaque	27.32	19.67	13	4811	3749	29565954
Cardiac flutter	26.31	19.67	10	4814	1660	29568043
Dependence on oxygen therapy	26.09	19.67	6	4818	170	29569533
Hypomagnesaemia	25.86	19.67	22	4802	17446	29552257
Lymphoedema	25.40	19.67	12	4812	3405	29566298
Melaena	24.90	19.67	28	4796	31148	29538555
Abdominal symptom	24.51	19.67	7	4817	475	29569228
Agitated depression	24.39	19.67	6	4818	228	29569475
Faeces discoloured	22.22	19.67	18	4806	13333	29556370
Spinal epidural haemorrhage	21.12	19.67	4	4820	42	29569661
Hypocalcaemia	20.82	19.67	21	4803	20644	29549059
Malaise	20.67	19.67	65	4759	159537	29410166
Bone abscess	20.37	19.67	5	4819	188	29569515

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Red blood cell sedimentation rate abnormal	111.90	14.78	64	17326	16242	64465100
Disability	103.40	14.78	55	17335	12117	64469225
Acute kidney injury	100.65	14.78	307	17083	448933	64032409
Hyponatraemia	95.35	14.78	155	17235	148184	64333158
Clear cell renal cell carcinoma	84.69	14.78	29	17361	2150	64479192
Fall	84.24	14.78	275	17115	416551	64064791
Confusional state	83.94	14.78	204	17186	260940	64220402
C-reactive protein abnormal	80.48	14.78	65	17325	28982	64452360
Multiple fractures	80.23	14.78	37	17353	6003	64475339
Lymphoproliferative disorder	63.86	14.78	30	17360	5073	64476269
Red blood cell count decreased	62.43	14.78	71	17319	48315	64433027
Upper gastrointestinal haemorrhage	60.18	14.78	60	17330	35160	64446182
Haematocrit decreased	57.05	14.78	72	17318	54583	64426759
Presbyacusis	54.74	14.78	22	17368	2553	64478789
Contraindicated product administered	52.76	14.78	100	17290	107729	64373613
Femur fracture	50.81	14.78	54	17336	34081	64447261
C-reactive protein increased	47.64	14.78	89	17301	94820	64386522
Pleural thickening	43.65	14.78	19	17371	2691	64478651
Heart rate	41.13	14.78	8	17382	56	64481286
Blood magnesium increased	40.45	14.78	19	17371	3212	64478130
Haematemesis	37	14.78	54	17336	46945	64434397
Pleural fibrosis	36.37	14.78	19	17371	4031	64477311
Blood pressure measurement	35.51	14.78	10	17380	386	64480956
Hip fracture	33.65	14.78	39	17351	27060	64454282
Melaena	33.05	14.78	55	17335	53493	64427849
Epigastric discomfort	32.02	14.78	21	17369	6790	64474552
Orthostatic hypotension	31.55	14.78	50	17340	46688	64434654
Starvation ketoacidosis	30.73	14.78	7	17383	112	64481230
Hypomagnesaemia	29.50	14.78	43	17347	37333	64444009
Large intestine polyp	29.48	14.78	24	17366	10813	64470529
Hyperkalaemia	29.24	14.78	76	17314	101053	64380289
Hypocalcaemia	28.64	14.78	45	17345	41708	64439634
Deafness neurosensory	28.38	14.78	19	17371	6355	64474987
Malaise	28.19	14.78	193	17197	396054	64085288
Colitis microscopic	28.03	14.78	20	17370	7412	64473930
Musculoskeletal pain	27.63	14.78	65	17325	81229	64400113
Joint swelling	27.51	14.78	123	17267	215259	64266083
Paraneoplastic rash	27.29	14.78	6	17384	81	64481261
Neutropenic sepsis	26.43	14.78	32	17358	23240	64458102
Peripheral swelling	25.63	14.78	118	17272	209035	64272307
Blindness cortical	24.66	14.78	9	17381	804	64480538
High frequency ablation	24.59	14.78	7	17383	281	64481061
Metabolic encephalopathy	24.45	14.78	19	17371	8006	64473336
Renal cell carcinoma	24.35	14.78	17	17373	6087	64475255
Blood pressure diastolic decreased	24.25	14.78	30	17360	22271	64459071
Cerebellar haematoma	23.44	14.78	8	17382	587	64480755
Chorea	22.71	14.78	11	17379	1989	64479353
Blood pressure systolic increased	21.89	14.78	44	17346	49409	64431933
Sudden death	21.80	14.78	27	17363	20069	64461273
Osteoporosis	21.77	14.78	40	17350	42040	64439302
Haemoglobin decreased	21.68	14.78	107	17283	194956	64286386
Cyst	21.48	14.78	21	17369	12006	64469336
Blood lactic acid	21.31	14.78	7	17383	456	64480886
Impaired quality of life	21.21	14.78	16	17374	6455	64474887
Microcytic anaemia	21.07	14.78	14	17376	4624	64476718
Femoral neck fracture	20.99	14.78	18	17372	8706	64472636
Parkinsonian rest tremor	20.50	14.78	6	17384	266	64481076
Hepatobiliary infection	20.44	14.78	4	17386	29	64481313
Rheumatoid arthritis	20.34	14.78	93	17297	164201	64317141
Agitated depression	19.94	14.78	6	17384	293	64481049
Infected neoplasm	19.86	14.78	6	17384	297	64481045
New onset diabetes after transplantation	19.47	14.78	5	17385	135	64481207
Drug-induced liver injury	19.45	14.78	41	17349	47602	64433740
Ear infection viral	19.19	14.78	5	17385	143	64481199
Swollen tongue	19.07	14.78	34	17356	34920	64446422
Swelling face	18.69	14.78	46	17344	59120	64422222
Narrow anterior chamber angle	18.45	14.78	5	17385	167	64481175
Right aortic arch	18.36	14.78	3	17387	6	64481336
Epileptic encephalopathy	18.08	14.78	6	17384	404	64480938
Dependence on oxygen therapy	18.05	14.78	6	17384	406	64480936
Faeces discoloured	18.02	14.78	28	17362	25701	64455641
Gastric antral vascular ectasia	17.51	14.78	7	17383	801	64480541
Photosensitivity reaction	17.47	14.78	23	17367	18150	64463192
Diverticulum intestinal	17.23	14.78	15	17375	7405	64473937
Subdural haemorrhage	17.13	14.78	13	17377	5290	64476052
Osteoarthritis	16.68	14.78	46	17344	63290	64418052
Apnoeic attack	16.13	14.78	6	17384	565	64480777
Discharge	16.10	14.78	7	17383	989	64480353
Reperfusion arrhythmia	15.84	14.78	5	17385	287	64481055
Toxicity to various agents	15.82	14.78	48	17342	363465	64117877
Megacolon	15.71	14.78	10	17380	3072	64478270
Alopecia	15.65	14.78	13	17377	165677	64315665
Hallucinations, mixed	15.61	14.78	13	17377	6039	64475303
Abdominal symptom	15.24	14.78	6	17384	659	64480683
Cardiac flutter	15.17	14.78	11	17379	4178	64477164
Gingival erosion	15.05	14.78	4	17386	124	64481218

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	B03AA02	BLOOD AND BLOOD FORMING ORGANS ANTIANEMIC PREPARATIONS IRON PREPARATIONS Iron bivalent, oral preparations
ATC	B03AD02	BLOOD AND BLOOD FORMING ORGANS ANTIANEMIC PREPARATIONS IRON PREPARATIONS Iron in combination with folic acid
MeSH PA	D018977	Micronutrients
MeSH PA	D014131	Trace Elements

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Contraception	indication	13197004
Anemia of prematurity	indication	47100003	DOID:11243
Megaloblastic anemia due to folate deficiency	indication	85649008	DOID:14026
Iron deficiency anemia	indication	87522002
Acne vulgaris	indication	88616000
Pregnancy, function	indication	289908002
Breastfeeding (mother)	indication	413712001
Amenorrhea	off-label use	14302001	DOID:13938
Female hypogonadism syndrome	off-label use	16041008
Polycystic ovaries	off-label use	69878008
Endometriosis	off-label use	129103003
Dysmenorrhea	off-label use	266599000
Abnormal uterine bleeding unrelated to menstrual cycle	off-label use	312984006
Menorrhagia	off-label use	386692008
Prevention of Fetal Neural Tube Defects during Pregnancy	off-label use
Heart valve disorder	contraindication	368009	DOID:4079
Peptic ulcer	contraindication	13200003	DOID:750
Hypercholesterolemia	contraindication	13644009
Constipation	contraindication	14760008	DOID:2089
Primary hyperoxaluria	contraindication	17901006	DOID:2977
Hyperphosphatemia	contraindication	20165001	DOID:0050459
Myocardial infarction	contraindication	22298006	DOID:5844
Gastroenteritis	contraindication	25374005	DOID:2326
Hypervitaminosis D	contraindication	27712000	DOID:9971
Sarcoidosis	contraindication	31541009	DOID:11335
Dehydration	contraindication	34095006
Depressive disorder	contraindication	35489007
Migraine	contraindication	37796009	DOID:6364
Hypertensive disorder	contraindication	38341003	DOID:10763
Hemosiderosis	contraindication	39011001	DOID:12119
Disorder of gallbladder	contraindication	39621005	DOID:0060262
Hypokalemia	contraindication	43339004
Body fluid retention	contraindication	43498006
Thrombosis of retinal vein	contraindication	46085004
Gastrectomy	contraindication	53442002
Hyperlipidemia	contraindication	55822004	DOID:1168
Benign mammary dysplasia	contraindication	57993004
Leber's optic atrophy	contraindication	58610003	DOID:705
Obstructive hyperbilirubinemia	contraindication	59848001
Hemolytic anemia	contraindication	61261009	DOID:583
Thrombophlebitis	contraindication	64156001	DOID:3875
Ulcerative colitis	contraindication	64766004	DOID:8577
Intermenstrual bleeding - irregular	contraindication	64996003
Hypercalcemia	contraindication	66931009	DOID:12678
Hyperparathyroidism	contraindication	66999008	DOID:13543
Diabetes mellitus	contraindication	73211009	DOID:9351
Hyperglycemia	contraindication	80394007	DOID:4195
Atrophic gastritis	contraindication	84568007	DOID:8929
Kidney disease	contraindication	90708001	DOID:557
Malignant neoplasm of liver	contraindication	93870000	DOID:3571
Kidney stone	contraindication	95570007
Anemia due to enzyme deficiency	contraindication	111577008
Hb SS disease	contraindication	127040003	DOID:10923
Deep venous thrombosis	contraindication	128053003
Liver function tests abnormal	contraindication	166603001
Angina pectoris	contraindication	194828000
Osteolysis	contraindication	203522001
Cerebrovascular accident	contraindication	230690007
Pulmonary thromboembolism	contraindication	233935004
Disease of liver	contraindication	235856003	DOID:409
Cholestasis of pregnancy	contraindication	235888006
Endometrial carcinoma	contraindication	254878006	DOID:2871
Hypertriglyceridemia	contraindication	302870006
Arteriosclerosis obliterans	contraindication	361133006	DOID:5160
Malignant tumor of cervix	contraindication	363354003	DOID:4362
Thromboembolic disorder	contraindication	371039008
Cardiovascular event risk	contraindication	395112001
Diverticular disease	contraindication	397881000
Hemochromatosis	contraindication	399187006	DOID:2352
Disorder of coronary artery	contraindication	414024009
Obesity	contraindication	414916001	DOID:9970
Estrogen receptor positive tumor	contraindication	416053008
Porphyria	contraindication	418470004
Hypertensive urgency	contraindication	443482000
Carcinoma of female breast	contraindication	447782002
Smokes tobacco daily	contraindication	449868002
Nonspecific Abnormal Papanicolaou Smear of Cervix	contraindication
Repeated Blood Transfusions	contraindication
Major Surgery with Prolonged Post-Operative Immobilization	contraindication

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
4017694	VUID
N0000146068	NUI
D01194	KEGG_DRUG
4017630	VANDF
4017694	VANDF
C0060276	UMLSCUI
CHEBI:31607	CHEBI
CHEMBL1200640	ChEMBL_ID
DB14491	DRUGBANK_ID
C031621	MESH_SUPPLEMENTAL_RECORD_UI
R5L488RY0Q	UNII
6433164	PUBCHEM_CID
24941	RXNORM
4723	MMSL
4919	MMSL
6955	MMSL
d03920	MMSL
000833	NDDF
387289009	SNOMEDCT_US
52108005	SNOMEDCT_US

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
CitraNatal Medley	HUMAN PRESCRIPTION DRUG LABEL	8	0178-0896	CAPSULE, GELATIN COATED	2 mg	ORAL	unapproved drug other	10 sections
BACMIN	HUMAN PRESCRIPTION DRUG LABEL	19	0682-3001	TABLET, COATED	27 mg	ORAL	UNAPPROVED DRUG OTHER	10 sections
O-Cal Prenatal Vitamin	HUMAN PRESCRIPTION DRUG LABEL	16	0813-0202	TABLET	15 mg	ORAL	UNAPPROVED DRUG OTHER	6 sections
PRENATAL PLUS	HUMAN PRESCRIPTION DRUG LABEL	15	10544-549	TABLET, FILM COATED	27 mg	ORAL	unapproved drug other	8 sections
Se-Natal 19	HUMAN PRESCRIPTION DRUG LABEL	15	13925-116	TABLET	29 mg	ORAL	unapproved drug other	15 sections
Se-Natal 19	HUMAN PRESCRIPTION DRUG LABEL	15	13925-116	TABLET	29 mg	ORAL	unapproved drug other	15 sections
Se-Natal 19 Chewable	HUMAN PRESCRIPTION DRUG LABEL	14	13925-117	TABLET, CHEWABLE	29 mg	ORAL	unapproved drug other	16 sections
Se-Tan PLUS	HUMAN PRESCRIPTION DRUG LABEL	13	13925-118	CAPSULE, GELATIN COATED	162 mg	ORAL	unapproved drug other	19 sections
Se-Tan PLUS	HUMAN PRESCRIPTION DRUG LABEL	13	13925-118	CAPSULE, GELATIN COATED	162 mg	ORAL	unapproved drug other	19 sections
PRENATAL PLUS	HUMAN PRESCRIPTION DRUG LABEL	15	15338-522	TABLET, FILM COATED	27 mg	ORAL	unapproved drug other	8 sections
PRENATAL PLUS	HUMAN PRESCRIPTION DRUG LABEL	15	17856-0668	TABLET, FILM COATED	27 mg	ORAL	UNAPPROVED DRUG OTHER	6 sections
C-Nate DHA	HUMAN PRESCRIPTION DRUG LABEL	13	23359-105	CAPSULE, GELATIN COATED	28 mg	ORAL	unapproved drug other	15 sections
Prenatal Plus Vitamins	HUMAN PRESCRIPTION DRUG LABEL	15	39328-106	TABLET	27 mg	ORAL	UNAPPROVED DRUG OTHER	7 sections
PNV-Select	HUMAN PRESCRIPTION DRUG LABEL	18	42192-320	TABLET, FILM COATED	27 mg	ORAL	unapproved drug other	10 sections
PNV-DHA	HUMAN PRESCRIPTION DRUG LABEL	10	42192-321	CAPSULE, GELATIN COATED	27 mg	ORAL	unapproved drug other	11 sections
PNV-DHA	HUMAN PRESCRIPTION DRUG LABEL	8	42192-323	CAPSULE, GELATIN COATED	27 mg	ORAL	unapproved drug other	11 sections
PNV-Omega	HUMAN PRESCRIPTION DRUG LABEL	13	42192-332	CAPSULE, GELATIN COATED	28 mg	ORAL	unapproved drug other	12 sections
Prenaissance	HUMAN PRESCRIPTION DRUG LABEL	9	42192-341	CAPSULE, LIQUID FILLED	29 mg	ORAL	UNAPPROVED DRUG OTHER	10 sections
PRENATAL PLUS	HUMAN PRESCRIPTION DRUG LABEL	15	42291-686	TABLET, FILM COATED	27 mg	ORAL	unapproved drug other	8 sections
PNV Prenatal VitaminPlus Vitamin A	HUMAN PRESCRIPTION DRUG LABEL	12	44946-1046	TABLET	27 mg	ORAL	UNAPPROVED DRUG OTHER	9 sections
PNV Prenatal Plus Multivitamin	HUMAN PRESCRIPTION DRUG LABEL	15	50090-0617	TABLET	27 mg	ORAL	Unapproved drug other	9 sections
PRENATAL PLUS	HUMAN PRESCRIPTION DRUG LABEL	15	50268-677	TABLET, FILM COATED	27 mg	ORAL	unapproved drug other	8 sections
Concept OB	HUMAN PRESCRIPTION DRUG LABEL	15	52747-620	CAPSULE	130 mg	ORAL	unapproved drug other	13 sections
Concept DHA	HUMAN PRESCRIPTION DRUG LABEL	15	52747-621	CAPSULE, LIQUID FILLED	53.50 mg	ORAL	unapproved drug other	7 sections
Integra F	HUMAN PRESCRIPTION DRUG LABEL	5	52747-711	CAPSULE	191.20 mg	ORAL	unapproved drug other	14 sections
Integra Plus	HUMAN PRESCRIPTION DRUG LABEL	10	52747-712	CAPSULE	191.20 mg	ORAL	unapproved drug other	12 sections
M-Natal Plus	HUMAN PRESCRIPTION DRUG LABEL	14	58657-170	TABLET	27 mg	ORAL	unapproved drug other	7 sections
PureVit DualFe Plus	HUMAN PRESCRIPTION DRUG LABEL	13	59088-112	CAPSULE	53 mg	ORAL	unapproved drug other	12 sections
Vitrexyl plus Iron	HUMAN PRESCRIPTION DRUG LABEL	18	59088-165	TABLET	27 mg	ORAL	unapproved drug other	13 sections
Prenatrix	HUMAN PRESCRIPTION DRUG LABEL	20	59088-166	TABLET	27 mg	ORAL	unapproved drug other	13 sections